Open Beta
TREN
MetriLume
TREN

US marketsUPB

SEC-sourced researchBeta

UPB

Upstream Bio, Inc.

Company comparison ↗

Data passport

CIK
0002022626
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Sep 17, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 2,370,000.0000 USD; December 2025: 2,854,000.0000 USD2.9M USD0 USD0December 2024December 2025
UPB · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20242,370,000.0000Mar 26, 2026
December 20252,854,000.0000Mar 26, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20252,854,000.0000-143,443,000.0000-133,275,000.0000353,772,000.000014,001,000.0000Mar 26, 2026
December 20242,370,000.0000-62,806,000.0000-59,172,000.0000481,719,000.000011,867,000.0000Mar 26, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$2.85MDecember 2025Mar 26, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$2.37MDecember 2024Mar 26, 202610-K
Net incomeNetIncomeLoss-$143.44MDecember 2025Mar 26, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$133.28MDecember 2025Mar 26, 202610-K
Total assetsAssets$353.77MDecember 2025Mar 26, 202610-K
Total liabilitiesLiabilities$14MDecember 2025Mar 26, 202610-K

New filings

Explore methodology ↗